These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27406906)

  • 1. A model to predict anti-tuberculosis activity: value proposition for marine microorganisms.
    Liu M; Grkovic T; Zhang L; Liu X; Quinn RJ
    J Antibiot (Tokyo); 2016 Aug; 69(8):594-9. PubMed ID: 27406906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New perspectives on natural products in TB drug research.
    Pauli GF; Case RJ; Inui T; Wang Y; Cho S; Fischer NH; Franzblau SG
    Life Sci; 2005 Dec; 78(5):485-94. PubMed ID: 16243360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting natural product value, an exploration of anti-TB drug space.
    Dashti Y; Grkovic T; Quinn RJ
    Nat Prod Rep; 2014 Aug; 31(8):990-8. PubMed ID: 24881816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of marine natural Products: Recent Advances in the discovery of Anti-Tuberculosis agents.
    Peng X; Zeng Z; Hassan S; Xue Y
    Bioorg Chem; 2024 Oct; 151():107699. PubMed ID: 39128242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New Drugs.
    Mascarello A; Chiaradia-Delatorre LD; Mori M; Terenzi H; Botta B
    Curr Pharm Des; 2016; 22(12):1561-9. PubMed ID: 26759082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitubercular Marine Natural Products.
    Wang L; Wang J; Liu J; Liu Y
    Curr Med Chem; 2018; 25(20):2304-2328. PubMed ID: 28088903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimycobacterial Metabolites from Marine Invertebrates.
    Daletos G; Ancheeva E; Chaidir C; Kalscheuer R; Proksch P
    Arch Pharm (Weinheim); 2016 Oct; 349(10):763-773. PubMed ID: 27561360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and Challenges for Natural Products as Novel Antituberculosis Agents.
    Farah SI; Abdelrahman AA; North EJ; Chauhan H
    Assay Drug Dev Technol; 2016; 14(1):29-38. PubMed ID: 26565779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New tuberculosis drugs on the horizon.
    Cole ST; Riccardi G
    Curr Opin Microbiol; 2011 Oct; 14(5):570-6. PubMed ID: 21821466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on tuberculosis pathogenesis and discovery of anti- tubercular drugs.
    Ntie-Kang F; Yong JN; Owono Owono LC; Sippl W; Megnassan E
    Curr Med Chem; 2014; 21(30):3466-77. PubMed ID: 25005178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug development against tuberculosis: Impact of alkaloids.
    Mishra SK; Tripathi G; Kishore N; Singh RK; Singh A; Tiwari VK
    Eur J Med Chem; 2017 Sep; 137():504-544. PubMed ID: 28628823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational medicinal chemistry for rational drug design: Identification of novel chemical structures with potential anti-tuberculosis activity.
    Koseki Y; Aoki S
    Curr Top Med Chem; 2014; 14(1):176-88. PubMed ID: 24236720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring anti-TB leads from natural products library originated from marine microbes and medicinal plants.
    Liu X; Chen C; He W; Huang P; Liu M; Wang Q; Guo H; Bolla K; Lu Y; Song F; Dai H; Liu M; Zhang L
    Antonie Van Leeuwenhoek; 2012 Oct; 102(3):447-61. PubMed ID: 22814612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Back to the future: a new 'old' lead for tuberculosis.
    Wright GD
    EMBO Mol Med; 2012 Oct; 4(10):1029-31. PubMed ID: 22987753
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimycobacterial activity of natural products and synthetic agents: pyrrolodiquinolines and vermelhotin as anti-tubercular leads against clinical multidrug resistant isolates of Mycobacterium tuberculosis.
    Ganihigama DU; Sureram S; Sangher S; Hongmanee P; Aree T; Mahidol C; Ruchirawat S; Kittakoop P
    Eur J Med Chem; 2015 Jan; 89():1-12. PubMed ID: 25462220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural products as leads for tuberculosis drug development.
    Salomon CE; Schmidt LE
    Curr Top Med Chem; 2012; 12(7):735-65. PubMed ID: 22283816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of new anti-tuberculosis drugs: the strategy of unconventional microbial culture and silencing gene activation].
    Teng T; Xie L; Xie J
    Sheng Wu Gong Cheng Xue Bao; 2018 Aug; 34(8):1306-1315. PubMed ID: 30152216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products.
    Prasasty VD; Cindana S; Ivan FX; Zahroh H; Sinaga E
    Comput Biol Chem; 2020 Apr; 85():107205. PubMed ID: 31981965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study of Anti-Tuberculosis Activity Behaviour of Natural Kaurane and Trachylobane Diterpenes Compared with Structural Properties Obtained by Theoretical Calculations.
    Soares ACF; Cabral MMW; Martins CHG; Ferreira AE; Bergamo PAS; Omosa LK; Midiwo JO; Parreira RLT; Heleno VCG
    Nat Prod Commun; 2017 May; 12(5):763-769. PubMed ID: 30496662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.